| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Erlotinib | CTRPv2 | pan-cancer | AAC | -0.072 | 0.06 |
| mRNA | BRD-K41334119 | CTRPv2 | pan-cancer | AAC | 0.15 | 0.06 |
| mRNA | apicidin | CTRPv2 | pan-cancer | AAC | 0.063 | 0.06 |
| mRNA | LAQ824 | GDSC1000 | pan-cancer | AAC | -0.066 | 0.06 |
| mRNA | BX-795 | GDSC1000 | pan-cancer | AAC | -0.066 | 0.06 |
| mRNA | CHIR-99021 | GDSC1000 | pan-cancer | AAC | -0.062 | 0.06 |
| mRNA | GDC-0449 | GDSC1000 | pan-cancer | AAC | -0.07 | 0.06 |
| mRNA | SB52334 | GDSC1000 | pan-cancer | AAC | 0.064 | 0.06 |
| mRNA | BRD-K34485477 | CTRPv2 | pan-cancer | AAC | 0.15 | 0.06 |
| mRNA | selumetinib:tretinoin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.072 | 0.06 |